119 related articles for article (PubMed ID: 7861176)
1. Dopamine transporter cysteine mutants: second extracellular loop cysteines are required for transporter expression.
Wang JB; Moriwaki A; Uhl GR
J Neurochem; 1995 Mar; 64(3):1416-9. PubMed ID: 7861176
[TBL] [Abstract][Full Text] [Related]
2. Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter.
Ferrer JV; Javitch JA
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9238-43. PubMed ID: 9689064
[TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains.
Lin Z; Wang W; Uhl GR
Mol Pharmacol; 2000 Dec; 58(6):1581-92. PubMed ID: 11093799
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.
Lin Z; Itokawa M; Uhl GR
FASEB J; 2000 Apr; 14(5):715-28. PubMed ID: 10744628
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition.
Lin Z; Wang W; Kopajtic T; Revay RS; Uhl GR
Mol Pharmacol; 1999 Aug; 56(2):434-47. PubMed ID: 10419565
[TBL] [Abstract][Full Text] [Related]
6. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain.
Lee FJ; Pristupa ZB; Ciliax BJ; Levey AI; Niznik HB
J Biol Chem; 1996 Aug; 271(34):20885-94. PubMed ID: 8702845
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.
Kitayama S; Shimada S; Xu H; Markham L; Donovan DM; Uhl GR
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7782-5. PubMed ID: 1502198
[TBL] [Abstract][Full Text] [Related]
8. Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter.
Whitehead RE; Ferrer JV; Javitch JA; Justice JB
J Neurochem; 2001 Feb; 76(4):1242-51. PubMed ID: 11181843
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter mutants selectively enhance MPP+ transport.
Kitayama S; Wang JB; Uhl GR
Synapse; 1993 Sep; 15(1):58-62. PubMed ID: 8310426
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions.
Itokawa M; Lin Z; Cai NS; Wu C; Kitayama S; Wang JB; Uhl GR
Mol Pharmacol; 2000 Jun; 57(6):1093-103. PubMed ID: 10825379
[TBL] [Abstract][Full Text] [Related]
11. Substrate transport and cocaine binding of human dopamine transporter is reduced by substitution of carboxyl tail with that of bovine dopamine transporter.
Lee SH; Cho HK; Son H; Lee YS
Neuroreport; 1997 Jul; 8(11):2591-4. PubMed ID: 9261833
[TBL] [Abstract][Full Text] [Related]
12. Delineating structure-function relationships in the dopamine transporter from natural and engineered Zn2+ binding sites.
Gether U; Norregaard L; Loland CJ
Life Sci; 2001 Apr; 68(19-20):2187-98. PubMed ID: 11358327
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine-533 of rat dopamine transporter: involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine.
Mitsuhata C; Kitayama S; Morita K; Vandenbergh D; Uhl GR; Dohi T
Brain Res Mol Brain Res; 1998 May; 56(1-2):84-8. PubMed ID: 9602072
[TBL] [Abstract][Full Text] [Related]
14. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis.
Chen N; Vaughan RA; Reith ME
J Neurochem; 2001 May; 77(4):1116-27. PubMed ID: 11359877
[TBL] [Abstract][Full Text] [Related]
15. Species differences in functions of dopamine transporter: paucity of MPP+ uptake and cocaine binding in bovine dopamine transporter.
Lee SH; Rhee J; Koh JK; Lee YS
Neurosci Lett; 1996 Aug; 214(2-3):199-201. PubMed ID: 8878118
[TBL] [Abstract][Full Text] [Related]
16. The human dopamine transporter forms a tetramer in the plasma membrane: cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs.
Hastrup H; Sen N; Javitch JA
J Biol Chem; 2003 Nov; 278(46):45045-8. PubMed ID: 14519759
[TBL] [Abstract][Full Text] [Related]
17. Evidence for distinct sodium-, dopamine-, and cocaine-dependent conformational changes in transmembrane segments 7 and 8 of the dopamine transporter.
Norregaard L; Loland CJ; Gether U
J Biol Chem; 2003 Aug; 278(33):30587-96. PubMed ID: 12773538
[TBL] [Abstract][Full Text] [Related]
18. Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism.
Lin Z; Uhl GR
Mol Pharmacol; 2002 Apr; 61(4):885-91. PubMed ID: 11901228
[TBL] [Abstract][Full Text] [Related]
19. Proline mutations induce negative-dosage effects on uptake velocity of the dopamine transporter.
Lin Z; Uhl GR
J Neurochem; 2005 Jul; 94(1):276-87. PubMed ID: 15953370
[TBL] [Abstract][Full Text] [Related]
20. Structure and function of extracellular loop 4 of the serotonin transporter as revealed by cysteine-scanning mutagenesis.
Mitchell SM; Lee E; Garcia ML; Stephan MM
J Biol Chem; 2004 Jun; 279(23):24089-99. PubMed ID: 15140876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
